| I-23 Chih-hsuan Hsin Hepatic impairment affects pharmacokinetics and pharmacodynamics of selatogrel, a novel subcutaneous P2Y12 receptor antagonist Wednesday 09:45-11:15 |
| I-23 Chih-hsuan Hsin Hepatic impairment affects pharmacokinetics and pharmacodynamics of selatogrel, a novel subcutaneous P2Y12 receptor antagonist Wednesday 09:45-11:15 |